Is TCM undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6
Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TCM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TCM (DKK62.2) is trading below our estimate of fair value (DKK109.05)
Significantly Below Fair Value: TCM is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TCM?
Key metric: As TCM is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for TCM. This is calculated by dividing TCM's market cap by their current
earnings.
What is TCM's PE Ratio?
PE Ratio
16.1x
Earnings
DKK 40.32m
Market Cap
DKK 638.96m
TCM key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: TCM is expensive based on its Price-To-Earnings Ratio (16.1x) compared to the European Consumer Durables industry average (13x).
Price to Earnings Ratio vs Fair Ratio
What is TCM's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
TCM PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
16.1x
Fair PE Ratio
20.2x
Price-To-Earnings vs Fair Ratio: TCM is good value based on its Price-To-Earnings Ratio (16.1x) compared to the estimated Fair Price-To-Earnings Ratio (20.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst TCM forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
DKK 62.20
DKK 82.50
+32.6%
3.0%
DKK 85.00
DKK 80.00
n/a
2
Nov ’25
DKK 71.80
DKK 82.50
+14.9%
3.0%
DKK 85.00
DKK 80.00
n/a
2
Oct ’25
DKK 72.00
DKK 82.50
+14.6%
3.0%
DKK 85.00
DKK 80.00
n/a
2
Sep ’25
DKK 69.00
DKK 72.50
+5.1%
10.3%
DKK 80.00
DKK 65.00
n/a
2
Aug ’25
DKK 59.80
DKK 73.00
+22.1%
9.6%
DKK 80.00
DKK 66.00
n/a
2
Jul ’25
DKK 57.40
DKK 73.00
+27.2%
9.6%
DKK 80.00
DKK 66.00
n/a
2
Jun ’25
DKK 66.20
DKK 68.00
+2.7%
17.6%
DKK 80.00
DKK 56.00
n/a
2
May ’25
DKK 50.80
DKK 63.00
+24.0%
11.1%
DKK 70.00
DKK 56.00
n/a
2
Apr ’25
DKK 51.40
DKK 63.00
+22.6%
11.1%
DKK 70.00
DKK 56.00
n/a
2
Mar ’25
DKK 49.80
DKK 51.00
+2.4%
17.6%
DKK 60.00
DKK 42.00
n/a
2
Feb ’25
DKK 55.00
DKK 51.00
-7.3%
17.6%
DKK 60.00
DKK 42.00
n/a
2
Jan ’25
DKK 45.50
DKK 51.00
+12.1%
17.6%
DKK 60.00
DKK 42.00
n/a
2
Dec ’24
DKK 40.20
DKK 51.00
+26.9%
17.6%
DKK 60.00
DKK 42.00
n/a
2
Oct ’24
DKK 49.50
DKK 75.00
+51.5%
20.0%
DKK 90.00
DKK 60.00
DKK 72.00
2
Sep ’24
DKK 60.00
DKK 75.00
+25.0%
20.0%
DKK 90.00
DKK 60.00
DKK 69.00
2
Aug ’24
DKK 66.20
DKK 75.00
+13.3%
20.0%
DKK 90.00
DKK 60.00
DKK 59.80
2
Jul ’24
DKK 66.40
DKK 75.00
+13.0%
20.0%
DKK 90.00
DKK 60.00
DKK 57.40
2
Jun ’24
DKK 76.20
DKK 80.00
+5.0%
25.0%
DKK 100.00
DKK 60.00
DKK 66.20
2
May ’24
DKK 73.60
DKK 80.00
+8.7%
25.0%
DKK 100.00
DKK 60.00
DKK 50.80
2
Apr ’24
DKK 67.00
DKK 82.50
+23.1%
21.2%
DKK 100.00
DKK 65.00
DKK 51.40
2
Mar ’24
DKK 71.40
DKK 80.00
+12.0%
25.0%
DKK 100.00
DKK 60.00
DKK 49.80
2
Feb ’24
DKK 73.00
DKK 94.50
+29.5%
36.5%
DKK 129.00
DKK 60.00
DKK 55.00
2
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.